€50.80
Your prediction
Drägerwerk AG & Co. KGaA VZO Stock
Drägerwerk AG Co. KGaA is a German medical and safety technology company. It operates through two segments: Dräger Safety and Dräger Medical. The Dräger Safety segment produces and sells personal protective equipment and gas detection technology for industries such as oil and gas, mining, and firefighting. The Dräger Medical segment provides medical technology products such as anesthesia machines, incubators, and ventilators for hospitals and clinics. With a history that dates back to 1889, Drägerwerk is one of the world's leading manufacturers in its respective markets, and its stock is listed on the Frankfurt Stock Exchange and over-the-counter markets under the symbol DRWKF.
Pros and Cons of Drägerwerk AG & Co. KGaA VZO in the next few years
Pros
Cons
Performance of Drägerwerk AG & Co. KGaA VZO vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Drägerwerk AG & Co. KGaA VZO | -0.390% | 2.204% | 3.134% | 13.966% | -1.734% | -31.909% | 10.870% |
| Drägerwerk AG & Co. KGaA ST | -0.220% | 1.367% | -1.111% | 12.658% | -0.224% | -35.971% | 13.088% |
| Agfa Gevaert N.V. | -3.030% | -0.168% | -7.031% | -58.895% | -18.269% | -71.046% | -69.314% |
| Ion Beam Applications S.A. | 1.060% | 0.915% | 6.602% | -18.673% | 14.731% | -26.116% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance, the financial statements of Drägerwerk (US symbol: DRWKF), a company operating in the Healthcare Equipment & Supplies industry, show a mixed bag of results. The company has seen some fluctuations in its financials over the past three years, and it's essential to dig deeper into the details to identify the key drivers behind these changes and assess the overall financial health of the business.
*Pros: *
Revenue Growth: Drägerwerk has maintained a relatively stable revenue growth, with an increase from €3.41 billion in 2020 to €3.32 billion in 2021 and €3.05 billion in 2022. This growth in revenue reflects a positive indication of the company's market performance and its ability to generate sales.
